Matches in Wikidata for { <http://www.wikidata.org/entity/Q37867251> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- Q37867251 description "article científic" @default.
- Q37867251 description "article scientifique" @default.
- Q37867251 description "articolo scientifico" @default.
- Q37867251 description "artigo científico" @default.
- Q37867251 description "artículu científicu espublizáu n'abril de 2011" @default.
- Q37867251 description "bilimsel makale" @default.
- Q37867251 description "scientific article published on 19 April 2011" @default.
- Q37867251 description "vedecký článok" @default.
- Q37867251 description "vetenskaplig artikel" @default.
- Q37867251 description "videnskabelig artikel" @default.
- Q37867251 description "vědecký článek" @default.
- Q37867251 description "wetenschappelijk artikel" @default.
- Q37867251 description "wissenschaftlicher Artikel" @default.
- Q37867251 description "наукова стаття, опублікована у квітні 2011" @default.
- Q37867251 description "научни чланак" @default.
- Q37867251 description "مقالة علمية نشرت في 19 أبريل 2011" @default.
- Q37867251 name "Reporting of myelotoxicity associated with emerging regimens for the treatment of selected solid tumors" @default.
- Q37867251 name "Reporting of myelotoxicity associated with emerging regimens for the treatment of selected solid tumors" @default.
- Q37867251 type Item @default.
- Q37867251 label "Reporting of myelotoxicity associated with emerging regimens for the treatment of selected solid tumors" @default.
- Q37867251 label "Reporting of myelotoxicity associated with emerging regimens for the treatment of selected solid tumors" @default.
- Q37867251 prefLabel "Reporting of myelotoxicity associated with emerging regimens for the treatment of selected solid tumors" @default.
- Q37867251 prefLabel "Reporting of myelotoxicity associated with emerging regimens for the treatment of selected solid tumors" @default.
- Q37867251 P1433 Q37867251-44D74FD0-81E5-4AA6-91D8-C5EBB35231D8 @default.
- Q37867251 P1476 Q37867251-F7D09583-2FC0-4573-9A2F-5CA6F707415E @default.
- Q37867251 P2093 Q37867251-07463BC2-8BB6-43D8-9120-0AAD8CDF8D20 @default.
- Q37867251 P2093 Q37867251-51F33D35-22E2-4F5C-A82E-14AFAE0158B0 @default.
- Q37867251 P2093 Q37867251-62BC6EE6-887E-4021-B1D3-D305CEB54B4E @default.
- Q37867251 P2093 Q37867251-D374B447-4DEA-4B39-AEFE-0048D75FF8A5 @default.
- Q37867251 P2093 Q37867251-D3F3C78C-4888-44E0-9129-A922C0A15E89 @default.
- Q37867251 P2093 Q37867251-EEC18B39-FF3C-4E8C-B063-FF1743B4DE9D @default.
- Q37867251 P304 Q37867251-1B14FFD7-FA2B-45C9-8BCE-D01A76539C9D @default.
- Q37867251 P31 Q37867251-8aa9bdf3-9a0a-472f-9eeb-c971c190690c @default.
- Q37867251 P31 Q37867251-CA0B5A48-94EA-4792-BBCC-6380AF9BBA9D @default.
- Q37867251 P356 Q37867251-A26F5C0E-F200-4098-9637-5BDD4E92EA62 @default.
- Q37867251 P433 Q37867251-E77C6A97-513F-4CD2-B0D0-A78EA86315D1 @default.
- Q37867251 P478 Q37867251-C78F0700-2B44-4A16-9B39-7DED5E7B7985 @default.
- Q37867251 P50 Q37867251-691CBD69-0222-4AD6-836B-48BD233CAB2A @default.
- Q37867251 P577 Q37867251-707F7B6A-C117-4867-86D9-FFC6B4906204 @default.
- Q37867251 P698 Q37867251-2779CC9C-E34D-4C7E-AF4F-986EFE84E2B2 @default.
- Q37867251 P356 J.CRITREVONC.2011.03.003 @default.
- Q37867251 P698 21507676 @default.
- Q37867251 P1433 Q15724423 @default.
- Q37867251 P1476 "Reporting of myelotoxicity associated with emerging regimens for the treatment of selected solid tumors" @default.
- Q37867251 P2093 "Arlene Chan" @default.
- Q37867251 P2093 "Jeffrey Crawford" @default.
- Q37867251 P2093 "Lyndah Dreiling" @default.
- Q37867251 P2093 "Mi Rim Choi" @default.
- Q37867251 P2093 "Shailendra Verma" @default.
- Q37867251 P2093 "Ted Vandenberg" @default.
- Q37867251 P304 "136-150" @default.
- Q37867251 P31 Q13442814 @default.
- Q37867251 P31 Q7318358 @default.
- Q37867251 P356 "10.1016/J.CRITREVONC.2011.03.003" @default.
- Q37867251 P433 "2" @default.
- Q37867251 P478 "81" @default.
- Q37867251 P50 Q38291860 @default.
- Q37867251 P577 "2011-04-19T00:00:00Z" @default.
- Q37867251 P698 "21507676" @default.